(UroToday.com) The 2025 SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Benjamin Garmezy discussing a phase 1 trial of mevrometostat (PF-06821497), a potent and ...

A novel inhibitor-loaded bilayer hybrid system based on the LDH inner layer and MOF outer layer is designed on an aluminum alloy 2A12 surface to improve corrosion performance. The hybrid film system ...

Purpose TLR7 and TLR8 (TLR7/8) are members of the Toll-Like Receptor family that recognize single strand RNA. Activation of TLR7/8 within immune cells elevates pro-inflammatory cytokines and type ...

The combination of a calcineurin inhibitor and an antimetabolite remains standard care for graft-versus-host disease (GVHD) prophylaxis in these patients.

SAN CARLOS, Calif., June 12, 2025--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will present new clinical data from three cornerstone hematology assets ...

Cortec claims to have developed the ‘world’s first’ certified industrially compostable vapour corrosion inhibitor paper to package protective metals, highlighting its 92% USDA -certified biobased ...

Patient-Tailored JAK Inhibitor Selection: Evaluating Ruxolitinib, Fedratinib, Pacritinib, and Momelotinib in Intermediate-Risk Disease EP: 20. Response Assessment: Monitoring Parameters and Molecular ...

Clinical results from next-generation investigational therapies demonstrate potential for deep, durable responses that support the advancement of pivotal studies and future regulatory filings Phase 1 ...

GPs can start treatment with certain heart failure drugs that previously had to be initiated by a specialist, NICE has said in updated guidance. Sodium-glucose cotransporter-2 (SGLT2) inhibitors and ...

In a statement released Tuesday, June 10, the California Big Pharma said trials of GS-1720, an investigational integrase strand transfer inhibitor, and/or GS-4182, an investigational capsid ...

DC-15442 is a potent small molecule STAT6 inhibitor, which is not a degrader or prodrug, being advanced as a safe dupilumab-in-a-pill alternative for patients BOSTON, June 10, 2025 /PRNewswire ...

DeepCure Announces DC-15442 as Development Candidate, an Oral STAT6 Inhibitor with 100% in vivo inhibition of pSTAT6 and comparable efficacy to dupilumab across disease models DeepCure Announces ...